Drugs / BPL1
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03630588 | Aug → Dec 2018 | obesity disorder | Technological Centre of Nutrition and Health, Spain | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BPL1 | “Probiotic BPL1” NCT03630588 ↗ |
| Known as | Bifidobacterium Lactis | “inactivated probiotic Bifidobacterium Lactis (BPL1)” NCT03630588 ↗ |